Table 1. Clinical characteristics and evolution of chronic dermal leishmaniasis patients.
Subject code | Isolated parasite | Lesion duration (months) | Lesion number | Lesion Type | Time of second sample (Days after treatment) | % Cureda |
111 | ND | 8 | 1 | Nodule | 2 | 50 |
112 | L. braziliensis | 6 | 2 | Ulcers | 1 | 100 |
113 | L. panamensis | 7 | 1 | Ulcer | Lost to followup | NA |
114 | L. panamensis | 6 | 3 | Ulcers | Lost to followup | NA |
116 | L. panamensis | 6 | 5 | Ulcers/plaque/mucosal | 1 | 80 |
117 | L. panamensis | 18 | 8 | Plaques/papules/mucosal | 24 | 100 |
118 | L. panamensis | 6 | 1 | Ulcer | Lost to followup | NA |
121 | L. panamensis | 20 | 3 | Plaques/Nodule | 1 | 90 |
209 | ND | 6 | 1 | Ulcer | 5 | 100 |
214 | ND | 24 | 1 | Ulcer | 2 | 60 |
216 | L. braziliensis | 240 | 1 | Ulcer | 2 | 80 |
217 | L. panamensis | 36 | 1 | Plaque | 2 | 100 |
218 | ND | 48 | 1 | Ulcer | 2 | 80 |
223 | ND | 6 | 3 | Plaques | 23 | 100 |
% of surface area of ulcer(s) or plaque(s) healed or volume of nodule(s) reduced at the end of treatment; ND: not determined because culture was not necessary or no strain was obtained; NA: not applicable.